Thesis (Pharmaceuticals) Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
47
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$13.5M
- Investors
-
13
Thesis (Pharmaceuticals) General Information
Description
Provider of supplements intended to make the brain more effective. The company's supplements are personalized according to the user's needs and provide on-demand focus, energy, and productivity, enabling consumers who struggle with brain fog and burnout to access a tailored product for their unique biology and daily activities.
Contact Information
Website
www.takethesis.comCorporate Office
- 30 West 24th Street
- Floor 11
- New York, NY 10010
- United States
Corporate Office
- 30 West 24th Street
- Floor 11
- New York, NY 10010
- United States
Thesis (Pharmaceuticals) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 02-May-2023 | $13.5M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 01-Sep-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jul-2019 | $60K | $5.16M | Completed | Startup | |
| 1. Seed Round | $5.1M | $5.1M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Thesis (Pharmaceuticals) Comparisons
Industry
Financing
Details
Thesis (Pharmaceuticals) Competitors (1)
One of Thesis (Pharmaceuticals)’s competitors is Opti-Nutra, a Corporation company based in Royal Leamington Spa, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Opti-Nutra | Corporation | Royal Leamington Spa, United Kingdom |
Thesis (Pharmaceuticals) Signals
Thesis (Pharmaceuticals) Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Emil Capital Partners | Venture Capital | Minority | ||
| Evolution VC Partners | Venture Capital | Minority | ||
| Spectre Holdings | Family Office | Minority | ||
| Studio Management | Venture Capital | Minority | ||
| Artfo Holdings | Family Office | Minority |
Thesis (Pharmaceuticals) FAQs
-
When was Thesis (Pharmaceuticals) founded?
Thesis (Pharmaceuticals) was founded in 2017.
-
Where is Thesis (Pharmaceuticals) headquartered?
Thesis (Pharmaceuticals) is headquartered in New York, NY.
-
What is the size of Thesis (Pharmaceuticals)?
Thesis (Pharmaceuticals) has 47 total employees.
-
What industry is Thesis (Pharmaceuticals) in?
Thesis (Pharmaceuticals)’s primary industry is Other Consumer Non-Durables.
-
Is Thesis (Pharmaceuticals) a private or public company?
Thesis (Pharmaceuticals) is a Private company.
-
What is Thesis (Pharmaceuticals)’s current revenue?
The current revenue for Thesis (Pharmaceuticals) is .
-
How much funding has Thesis (Pharmaceuticals) raised over time?
Thesis (Pharmaceuticals) has raised $27.1M.
-
Who are Thesis (Pharmaceuticals)’s investors?
Emil Capital Partners, Evolution VC Partners, Spectre Holdings, Studio Management, and Artfo Holdings are 5 of 13 investors who have invested in Thesis (Pharmaceuticals).
-
Who are Thesis (Pharmaceuticals)’s competitors?
Opti-Nutra is a competitor of Thesis (Pharmaceuticals).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process